FDA approved LUMAKRAS for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer
On May 28, 2021, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved LUMAKRAS (sotorasib)…
On May 28, 2021, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved LUMAKRAS (sotorasib)…
On May 21, 2021, the the U.S. Food and Drug Administration (FDA) approved Rybrevant (amivantamab-vmjw) as the first…
On Apr. 26, 2021, Moderna announced that it had entered into an agreement with Sanofi for fill/finish sterile…
On Jan. 12, 2021, a team researchers from the University of Texas Southwestern (UTSW) announced they had identified…
On Jan. 8, 2021, the American Cancer Society reported that the death rate from cancer in the U.S….
On Dec. 18, 2020, the the U.S. Food and Drug Administration (FDA) approved AstraZeneca’s Tagrisso (osimertinib) as the…
On Nov. 24, 2020, Northwestern University researchers announced they had developed a new artificial intelligence (A.I.) platform that…
On Nov. 13, 2020, Agilent Technologies announced it had received U.S. Food and Drug Administration (FDA) approval for…
On Nov. 4, 2020, McGill University Professor William Foulkes awarded 2020 Wilder-Penfield Prize for research in the genetics…
On Oct. 28, 2020, Seagen announced the closing of a $1.0 billion equity investment by Merck in 5.0…
On Nov. 9, 2020, after more than two years of reconstruction efforts, scientists from the Fred Hutchinson Cancer…
On Sept. 14, 2020, Pascal Biosciences and SoRSE Technology announced they had entered into a collaborative research agreement…
On Sept. 9, 2020, NanoString Technologies announced the formation of the GeoMx Translational Leadership Network (GTLN). The GTLN…
On Aug. 24, 2020, a published study led by the Universities of Oxford and Birmingham found that, compared…
On Aug. 3, 2020, Todos Medical announced a partnership with PATHNOVA, a Singapore-based clinical laboratory, for the Company’s…
On Jun. 10, 2020, African Americans who smoke are nearly 2.5 times more likely to have a stroke…
On May 6, 2020, the U.S. Food and Drug Administration (FDA) approved Tabrecta (capmatinib) for the treatment of…
On Apr. 22, 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Trodelvy (sacituzumab govitecan-hziy),…
On Apr. 17, 2020, as part of Project Orbis, the U.S. Food and Drug Administration (FDA) approved Seagen’s…
On Apr. 15, 2020, Bellicum Pharma announced closing of the sale of its Houston facility to The University…
On Apr. 6, 2020, the National Cancer Institute awarded of $14.54 million to Roswell Park Comprehensive Cancer Center…
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…
On Mar. 19, 2020, The UArizona Cancer Center announced it was awarded a five-year, $6.9 million prestigious Program…
On Mar. 9, 2020, Winship Cancer Institute’s multiple myeloma team was awarded a $5 million grant from The…
On Mar. 2, 2020, Gilead Sciences announced it had acquired Forty Seven for $95.50 per share in cash…
On Feb. 20, 2020, Tim Boyle, CEO of Columbia Sportswear, and his wife, Mary, made a $10 million…
On Feb. 19, 2020, the Cancer Prevention & Research Institute of Texas (CPRIT) announced it had awarded 55…
On Jan. 27, 2020, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had recruited its…
On Jan. 16, 2020, the Barbara Ann Karmanos Cancer Institute received the President’s Trophy for the second year…
On Dec. 23, 2019, the Barbara Ann Karmanos Cancer Institute received the 2020 Women’s Choice Award as one…